We have created MASSIVE manufacturing capacity for mRNA vaccines for SARS-CoV-2, including supply chain logistics for raw ingredients and similar. How well will this translate to quick production of any new mRNA vaccines?
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list